Psoriasis Drug May Have Some Cardiometabolic Benefits Psoriasis Drug May Have Some Cardiometabolic Benefits

Nonrandomized trial shows 5%-6% reduction in both visceral and subcutaneous fat, but no effect on aortic vascular inflammation.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Dermatology News Source Type: news